The Bracken Group

The professional services firm for the life sciences industry

Scientists, physicians, and industry veterans: our ecosystem of experts supports your program from first strategy to final filing.

Our areas of concentration

From early strategy to regulatory approval

Meet the whole team

Radiopharmaceuticals

Explore radiopharma

Regulatory affairs

Explore regulatory

Medical imaging in clinical trials

Explore medical imaging
Which products?

*Including dalbavancin, anidulafungin, luspatercept, ixabepilone, trabectedin, cetuximab, necitumumab, sorafenib, regorafenib, tislelizumab, pamiparib, bevacizumab, vusolimogene oderparepvec (RP1), tofacitinib, and vaccines for hepatitis A, hepatitis A/B, DTaP, and Lyme disease. Figures reflect the combined experience of The Bracken Group’s consultants across their careers, including work completed before joining Bracken.

Listen and watch

Our ongoing media series

Fractals episode cover
Fractals · Latest episode

Decoding the Real-World Language of Healthcare

Jo Halliday from Talking Medicines

Listen on our site
Radiopharma Roundtable Series

Past sessions, recaps & resources

Expert peer conversations on the future of radiopharmaceutical development.

Session recordingsRecapsWhite papers
Testimonials

Voices from our Ecosystem

Our clients know what we’re capable of. Here’s why they choose to work with us.

Creative services
“Bracken has been a tremendous asset to our team. Their marketing and industry expertise, attention to detail, and data-driven approach have helped us deliver consistently high-quality content.”
Ryan MonteMarketing Director, Advarra
Client experience
“[Our team] really appreciates how time sensitive and focused the Bracken team is. They don’t just show up on time, they’re very sensitive to our time as a whole. It means a lot on a very busy schedule.”
Mike KeensCEO
Creative services
“Working with Bracken, we have seen a very noticeable growth in our social media follower base, our website traffic and in the number of high-quality contacts being generated through the LinkedIn campaign, with our cost per lead coming in below expectations.”
Jack LeggatDirector of Business Development and Marketing, The Clinician
Data & CRM
“Bracken CRM has helped us identify very targeted segments in an efficient manner.”
Lara TriozziCEO/Founder, MarketLauncher inc
FAQ

Frequently asked questions

What does The Bracken Group do?
The Bracken Group is a professional services firm for the life sciences industry. Our scientists, physicians, and industry veterans advise pharma, biotech, and device companies on radiopharmaceutical development, regulatory strategy, and medical imaging in clinical trials. Beyond those core areas, we cover clinical trial strategy, M&A due diligence, fractional leadership, and creative and data services. Clients can add Bracken experts to their team or have Bracken run a function outright.
Which companies does Bracken work with?
Bracken works with pharmaceutical, biotech, radiopharmaceutical, and medical device sponsors at every stage, from preclinical startups to global organizations. We also support imaging core labs, CROs, service providers, and investors evaluating life science assets.
Can Bracken support an early-stage biotech with no in-house regulatory team?
Yes. Bracken’s regulatory experts can serve as your interim Head of Regulatory Affairs or regulatory director while you build a permanent team. That covers pre-IND communications, FDA meeting preparation, and IND submission. Our fractional model embeds experienced people directly in your team, so you get senior regulatory judgment without a full-time hire.

We’re here to make your life science easier—today and tomorrow.

Let’s get started.